Press Releases

Press Releases

Sosei Group Corporation announces that Heptares Therapeutics, the wholly-owned subsidiary of Sosei, has signed a share purchase agreement that will allow the acquisition of 100% in G7 Therapeutics, a privately held drug discovery and development company based in Switzerland, for CHF 12 million cash. The strategic acquisition broadens and strengthens…

Press Releases

Onxeo S.A., a biopharmaceutical company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announced having received communication from the European Patent Office (EPO) informing its intention to grant a new patent covering especially the particular nucleic acid molecule comprised within…

Press Releases

Mylan N.V. announced that the company has signed an agreement with the Medicines Patent Pool (MPP) to expand access to chronic hepatitis C medicines in developing countries. The agreement licenses Mylan to produce and market a generic version of Bristol-Myers Squibb's DAKLINZA™ (daclatasvir) Tablets, 30 mg and 60 mg, for…

Press Releases

Intec Pharma Ltd., a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces it has entered into an agreement with the Michael J. Fox Foundation for Parkinson's Research (MJFF) to support patient recruitment and retention support for the Intec Pharma's pivotal Phase…

Press Releases

Having the right contacts and a good network are indispensible in the business world. To help exhibitors and visitors make business contacts that suit them to a tee, for the first time ever analytica 2017 will feature a platform for pre-arranged meetings at a Buyer-Seller Forum. Vietnam's leading trade fair…

Press Releases

Research and Markets has announced the addition of the "Drug Discovery Technology Subscription" newsletter to their offering. The Drug Discovery Technology (DDT) Alert is Technical Insights' new technology research subscription that reports and analyzes the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights…

Press Releases

Research and Markets has announced the addition of the "Dermatomyositis Global Clinical Trials Review, H2, 2016" clinical trials to their offering. Dermatomyositis Global Clinical Trials Review, H2, 2016 Summary The author's clinical trial report, Dermatomyositis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatomyositis clinical trials scenario. This…

Press Releases

Research and Markets has announced the addition of the "Global Halal Pharmaceuticals Market Analysis & Trends - Product Type, Drug Classes, Source Material - Forecast to 2025" report to their offering. Some of the prominent trends that the market is witnessing include growing need for certified medicines is propelling regulatory…

Press Releases

Neurotrope, Inc., a company focused on developing drugs to treat neurodegenerative diseases including Alzheimer's disease, today issued a statement on Eli Lilly's experimental drug solanezumab.  Lilly stated that, based upon results from its recent Phase 3 clinical trial, solanezumab failed to improve cognition of patients with mild Alzheimer's disease. Dr.…

Press Releases

Juno Therapeutics, Inc., a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced that it has voluntarily placed on hold the Phase II clinical trial of JCAR015 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia, known as the…